Excited to join our colleagues in the BSG and to present with Arpan Patel, MD PhD (he/him/his) and Manisha Verma on #palliativehepatology - looking forward to this!

The Division is delighted to announce that MGH has been ranked second best specialized hospital in the world for gastroenterology by Newsweek! newsweek.com/worlds-best-sp…

Super excited about this new AASLD Thought Leaders Series moderated by Ray Chung AASLD President🙌 The first talk will be presented by Dr. Diehl Duke GI & Dr.Rinella NM Gastroenterology & GI Surgery at 5-6 PM ET 10/20 Wed 👉aasld.org/event/webinar-… #LiverTwitter

Join us at TLM, starting Friday

Thank you AASLD and AASLD Foundation for supporting #palliativehepatology through the years and supporting our LiverPal study! Areej El-Jawahri @VjacksonJackson Ray Chung John Donlan Teresa Indriolo MGH Division of Gastroenterology MGH Palliative Care & Geriatric Medicine #livertwitter

Atorvastatin modulates YAP, AKT, and metallothionein pathways, which are implicated in HCC development, and attenuates a clinical HCC risk gene signature in in vitro models of HCV infection and NAFLD. #OpenAccess #HCV #NAFLD #LiverTwitter #VisualAbstract aasldpubs.onlinelibrary.wiley.com/doi/10.1002/he…

I'm so glad to be onsite, in-person, for ALEH Congress 2022. If our paths cross, please say hello! #ALEH22

Snapshots from this past weekend in Philly of our Emerging Topic Conferences! Social Disparities in Chronic Liver Disease, and Controversies & Consensus in Alcohol-Associated Liver Disease. #LiverTwitter

Hey #livertwitter! We just updated our AASLD expert panel guidance on #COVID19. This new document consolidates our previous 2 documents into a concise 12-page (including references) practical guide. Check it out! AASLD.org/ClinicalInsigh…

Excited to connect with folks at #TLM22 and learn more about viral hepatitis elimination. #nohep #livertwitter

So proud of Paige who received AASLD Foundation Early Career Investigator Award in Healthcare Disparities Research! She will be giving an oral on our work on diversity in cirrhosis clinical trials #TLM22 Lauren Nephew MD, MSCE Patricia Jones Bharati Kochar MGH Division of Gastroenterology AASLD Ray Chung

As #thelivermeeting comes to a close today, as does my whirlwind Bigelow block at MGH IM Residents, grateful for the opportunity to learn from the hepatology giant, Ray Chung, about how he thinks about cirrhosis and patients with decompensation!

This is huge. Actions, not words. I cannot wait to celebrate the inaugural AASLD-AMFDP scholar and have them join our Amos family! Rotonya Carr ABGH George Alba @Ndichu_Muiru Utibe R. Essien, MD MPH J. Sawalla Guseh, M.D. Camille E. Powe MD Opeyemi Olabisi Dominique D. Bailey, MD, MSEd Lachelle Dawn Tamryn Fowler Gray, PhD, RN, MPH

Please join us in congratulating and welcoming our 2024 Transplant Hepatology Fellows, Drs. Xing Li and Alan Noll, MD who have just been matched. Welcome aboard! 👋 🎉 #livertwitter #GITwitter

Looking forward to presenting our work with Nadia Alatrakchi Ray Chung #GeorgLauer on a single-cell atlas of HCV patients' liver immune cells before and after being cured of HCV at the Liver Congress #EASLCongress EASLnews events-apps.easl.eu/easl2023/en-GB…

Excited to share our lab’s new story online in Cell Metabolism today! We show hepatic reductive stress (elevated NADH/NAD+) activates the transcription factor ChREBP in the liver. We think this helps explain longstanding observed metabolic phenotypes with alcohol use, obesity,

Join us in congratulating Ashley Spann on receiving the prestigious Inaugural Harold Amos Medical Faculty Development Program (AMFDP) Hepatology Award! We can't wait to see all you accomplish. 🎉 bit.ly/49aLVHp #AASLDAmos Vanderbilt Health

Big month for #MASLD trials - as we discuss costs of medications, nice to see the potential of low-cost alternatives. Congratulations to my favorite Tracey Simon Khalili (proud of you friend) and Rob Wilechansky Kathleen Corey Rohit Loomba Ray Chung Andy Chan MGH Division of Gastroenterology #livertwitter #mash

In this mixed-methods study of 372 transplant-ineligible patients with cirrhosis w/ severe AKI (ATN or HRS), we found that ~1 in 6 of those who received RRT were alive in 6 months - work led by Paige McLean Diaz in Digestive Diseases and Sciences #palliativehepatology #ACLF